Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients

Fertility and Sterility

Volumn 92, Issue 6, 2009, Pages 2078-2081

  Karkanaki, Artemis ^a   Piouka, Athanasia ^a   Katsikis, Ilias ^a   Farmakiotis, Dimitrios ^a   Macut, Djuro ^b   Panidis, Dimitrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANDROGEN; FOLLITROPIN; HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN;

ANDROGEN BLOOD LEVEL; ANOVULATION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLISM; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL;

ADIPONECTIN; BIOLOGICAL MARKERS; BODY WEIGHT; FEMALE; GENETIC HETEROGENEITY; HUMANS; INSULIN; PHENOTYPE; POLYCYSTIC OVARY SYNDROME;

EID: 70949104178     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.06.034     Document Type: Article

References (46)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 333 (1995) 853-861
2. Ehrmann D.A. Polycystic ovary syndrome. N Engl J Med 352 (2005) 1223-1236
3. Ehrmann D.A., Barnes R.B., Rosenfield R.L., Cavaghan M.K., and Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22 (1999) 141-146
4. Kelly C.J.G., Speirs A., Gould G.W., Petrie J.R., Lyall H., and Connell J.M.C. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002) 742-746
5. Lobo R.A., and Carmina E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 132 (2000) 989-993
6. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
7. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril 81 (2004) 19-25
8. Piouka A., Farmakiotis D., Katsikis I., Macut D., Gerou S., and Panidis D. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab 296 (2009) E238-E243
9. Zawadski J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A., Givens J.R., and Haseltine F. (Eds). Polycystic ovary syndrome. Boston: Blackwell Scientific (1992) 377-84
10. Diamanti-Kandarakis E., and Panidis D. Unraveling the phenotyping map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol 67 (2007) 735-742
11. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91 (2009) 456-488
12. Yilmaz M., Bukan N., Demirci H., Oztürk C., Kan E., Ayvaz G., et al. Serum resistin and adiponectin levels in women with polycystic ovary syndrome. Gynecol Endocrinol 25 (2009) 246-252
13. Fasshauer M., and Paschke R. Regulation of adipocytokines and insulin resistance. Diabetologia 46 (2003) 1594-1603
14. Trujillo M.E., and Scherer P.E. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257 (2005) 167-175
15. Hug C., and Lodish H.F. The role of the adipocyte hormone adiponectin in cardiovascular disease. Curr Opin Pharmacol 5 (2005) 129-134
16. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
17. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
18. Ardawi M.S., and Rouzi A.A. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Fertil Steril 83 (2005) 1708-1716
19. Carmina E., Bucchieri S., Mansueto P., Rini G., Ferin M., and Lobo R.A. Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome. Fertil Steril 91 (2009) 1332-1335
20. Carmina E., Orio F., Palomba S., Longo R.A., Cascella T., Colao A., et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med 119 (2006) 356.e1-356.e6
21. Escobar-Morreale H.F., Villuendas G., Botella-Carretero J.I., Alvarez-Blasco F., Sanchón R., Luque-Ramírez M., et al. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod 21 (2006) 257-265
22. Glintborg D., Andersen M., Hagen C., Frystyk J., Hulstrom V., Flyvbjerg A., et al. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol 155 (2006) 337-345
23. Sepilian V., and Nagamani M. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. J Soc Gynecol Investig 12 (2005) 129-134
24. Sieminska L., Marek B., Kos-Kudla B., Niedziolka D., Kajdaniuk D., Nowak M., et al. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters. J Endocrinol Invest 27 (2004) 528-534
25. Orio F., Palomba S., Cascella T., Di Biase S., Labella D., Russo T., et al. Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome. J Clin Endocrinol Metab 89 (2004) 110-115
26. Orio Jr. F., Palomba S., Cascella T., Milan G., Mioni R., Pagano C., et al. Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 2619-2623
27. Panidis D., Kourtis A., Farmakiotis D., Mouslech T., Rousso D., and Koliakos G. Serum adiponectin levels in women with polycystic ovary syndrome. Hum Reprod 18 (2003) 1790-1796
28. Spranger J., Mohlig M., Wegewitz U., Ristow M., Pfeiffer A.F., Schill T., et al. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol 61 (2004) 738-746
29. Gulcelik N.E., Aral Y., Serter R., Demir Y., and Culha C. Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 22 (2006) 511-515
30. Ducluzeau P.H., Cousin P., Malvoisin E., Bonet H., Vidal H., Laville M., et al. Glucose-to-insulin ratio rather than sex-hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab 88 (2003) 3626-3631
31. Panidis D., Farmakiotis D., Rousso D., Katsikis I., Kourtis A., and Diamanti-Kandarakis E. Serum luteinizing hormone levels are markedly increased and significantly correlated with 4-androstenedione levels in lean women with polycystic ovary syndrome. Fertil Steril 84 (2005) 538-540
32. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocrinol Rev 26 (2005) 439-451
33. Chandran M., Phillips S.A., Ciaraldi T., and Henry R.R. Adiponectin: more than just another fat cell hormone?. Diabetes Care 26 (2003) 2442-2450
34. Diez J.J., and Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148 (2003) 293-300
35. Ekmekci H., and Ekmekci O. The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thrombosis/Hemostasis 12 (2006) 163-168
36. Aroda V., Ciaraldi T., Chang S., Dahan M., Chang R.J., and Henry R.R. Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin ratio. Fertil Steril 89 (2008) 1200-1208
37. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implication for pathogenesis. Endocrinol Rev 18 (1997) 774-800
38. Chang R.J., Nakamura R.M., Jud H.L., and Kaplan S.A. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57 (1983) 356-359
39. Singer S., Pilpel N., Koren I., Boiko V., Hemi R., Pariente C., et al. Adiponectin levels in adolescent girls with polycystic ovary syndrome. Clin Endocrinol (2009) [Epub ahead of print]
40. Pasquali R., Venturoli S., Paradisi R., Capelli M., Parenti N., and Melchionda N. Insulin and C-peptide levels in obese patients with polycystic ovaries. Horm Metab Res 14 (1982) 284-287
41. Shoupe D., Kumar D.D., and Lobo R.A. Insulin resistance in polycystic ovary syndrome. Am J Obstet Gynecol 147 (1983) 588-592
42. Chang W.Y., Knochenhauer E.S., Bartolucci A.A., and Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 83 (2005) 1717-1723
43. Toulis K.A., Goulis D.G., Farmakiotis D., Georgopoulos N.A., Katsikis I., Tarlatzis B.C., et al. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 15 (2009) 297-307
44. Diamanti-Kandarakis E., Kouli C., Alexandraki K., and Spina G. Failure of mathematical models to accurately assess insulin resistance in lean, overweight or obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 89 (2004) 1273-1276
45. Trader BC, Pall M, Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in a group of women presenting with oligomenorrhea or hirsutism: NIH 1990 vs. Rotterdam 2003 criteria. In: The 88th Annual Meeting of the Endocrine Society. Boston, MA, June 24-28, 2006.
46. Jonard S., and Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 10 (2004) 107-117